![]() |
市場調查報告書
商品編碼
1891503
牙科骨移植替代材料市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2024-2032 年)Dental Bone Graft Substitutes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast, 2024-2032 |
||||||
隨著牙科專業人士越來越依賴生物基和合成材料來恢復骨量和支持植牙手術,全球牙科骨移植替代材料市場持續擴張。根據最新數據,受牙周病、牙齒脫落和牙齒斷裂盛行率上升的推動,該市場在 2024 年的價值將達到 3.078 億美元。預計到 2025 年,該市場將達到 3.281 億美元,這主要得益於植牙技術的日益普及和先進植牙材料的出現。到 2032 年,全球市場預計將顯著增長至 5.294 億美元,這反映了再生生物材料的廣泛應用和全球手術量的增長。
牙科骨移植替代材料包括同種異體移植、合成材料、脫礦骨基質和異種移植,旨在修復缺失或受損的骨組織。這些替代材料模擬天然骨骼的結構並促進再生,因此在齒槽骨增高術、上顎竇提升術和植體穩定等手術中至關重要。
市場概覽與區域趨勢
2024年,北美維持領先地位,市佔率達47.69%(價值1.468億美元)。這主要得益於牙科植牙手術量大、患者意識高以及新型植牙解決方案的不斷湧現。包括美國FDA批准的3D列印再生骨移植材料在內的創新技術進一步鞏固了該地區的領先地位。
歐洲佔第二大市場佔有率,這得益於其強大的研發投入和不斷增加的策略性收購。像 Geistlich Pharma AG 這樣的公司正透過收購和聯合培訓專案拓展業務,進一步促進產品推廣。
預計亞太地區在預測期內將達到最高的複合年增長率。快速成長的驅動因素包括牙科疾病的增加、人口老化促使齒槽骨再生需求上升以及製造商投資的增加。由於手術量增加和技術進步,日本、中國和印度正在成為關鍵市場。
拉丁美洲以及中東和非洲地區的市場接受度也在提高,這得益於醫療基礎設施的改善、病患意識的增強以及醫療旅遊業的蓬勃發展。
主要市場驅動因子
根據世界衛生組織 (WHO) 的數據,全球牙周病和齲齒發病率的上升顯著推動了對骨移植手術的需求。 5.14億兒童患有乳牙齲齒,20億成年人患有恆牙齲齒。各公司持續研發先進的生物相容性骨移植替代材料。例如,2024年2月,Geistlich Pharma推出了Varos Granules,這是一種脫礦異體骨移植材料,適用於各種牙科應用。
一個值得關注的市場趨勢是,可根據患者解剖結構量身定制的3D列印再生植入物正被迅速採用。這些創新技術能夠改善骨骼完整性和臨床療效。 Desktop Metal公司的CMFlex 3D列印植入物於2022年12月獲得美國FDA批准,這顯示牙科領域對先進技術的接受度正在不斷提高。
旨在拓展生物材料產品組合併改善再生醫學產品可近性的合作正在增強市場實力。 Biocomposites 於 2023 年收購 Artus,以及 Zimmer Biomet 與 RTI Surgical 合作支持美國退伍軍人,都是業界合作如何加速產品推廣和臨床應用的良好例證。
市場挑戰
儘管成長前景強勁,但挑戰依然存在。一些國家對植入手術的保險覆蓋範圍限制增加了患者的自付費用,並影響了產品的普及率。此外,免疫反應、骨誘導性有限和骨形成不足等潛在風險可能會限制某些地區的臨床應用。嚴格的監管準則進一步延緩了產品審批和市場滲透。
依產品類型
2024年,脫礦骨基質(DBM)市場佔有率最大,這主要得益於對需要高級骨再生技術的種植手術的高需求。同時,由於合成骨移植替代品易於取得、成本效益高且具有良好的生物相容性,預計其成長速度最快。
依型態
2024年,顆粒狀骨移植替代物將主導市場,這主要歸功於其促進成骨細胞附著和刺激骨形成的表面特性。由於產品不斷創新,糊狀和塊狀骨移植替代物的市場佔有率預計將會擴大。
依最終使用者
2024年,個體執業者將引領市場,這主要得益於患者的強烈偏好以及眾多開展骨移植手術的獨立牙科診所。同時,由於集中採購和手術數量的增加,預計牙科服務機構/集團診所將迎來快速增長。
The global dental bone graft substitutes market continues to expand as dental professionals increasingly depend on biologic and synthetic materials to restore bone volume and support implant procedures. According to the latest data, the market was valued at USD 307.8 million in 2024, driven by the rising prevalence of periodontal disease, tooth loss, and dental fractures. In 2025, the market is projected to reach USD 328.1 million, supported by growing adoption of implant dentistry and availability of technologically advanced grafting materials. By 2032, the global market is expected to grow significantly to USD 529.4 million, reflecting the expanding use of regenerative biomaterials and higher procedural volumes worldwide.
Dental bone graft substitutes include allografts, synthetic materials, demineralized bone matrices, and xenografts designed to restore missing or damaged bone tissue. These substitutes mimic the structure of natural bone and promote regeneration, making them essential in procedures such as ridge augmentation, sinus lifts, and implant stabilization.
Market Overview and Regional Performance
North America dominated the market in 2024 with a 47.69% share, equivalent to USD 146.8 million, driven by a high volume of dental implant surgeries, strong patient awareness, and continuous launches of new grafting solutions. Innovative technologies, including U.S. FDA-approved 3D-printed regenerative bone grafts, continue to strengthen the region's leadership position.
Europe held the second-largest share, supported by strong R&D investments and an increasing number of strategic acquisitions. Companies such as Geistlich Pharma AG are expanding their presence through acquisitions and collaborative training programs, further enhancing product adoption.
The Asia Pacific region is expected to record the highest CAGR during the forecast period. Rapid growth is driven by increasing dental disorders, a rising geriatric population needing alveolar bone regeneration, and expanding investments by manufacturers. Japan, China, and India are emerging as key markets due to increasing procedural volumes and growing technological advancements.
Latin America and the Middle East & Africa are also experiencing growing adoption due to improving healthcare infrastructure, rising patient awareness, and expanding medical tourism.
Key Market Drivers
The increasing global incidence of periodontal disease and tooth decay-such as 514 million children with primary decay and 2 billion adults affected by permanent decay, according to the WHO-has significantly increased the demand for bone grafting procedures. Companies continue to launch advanced, more biocompatible graft substitutes. For example, in February 2024, Geistlich Pharma AG introduced Vallos granules, a demineralized allograft designed for various dental applications.
A notable trend in the market is the rapid adoption of 3D-printed regenerative grafts, which can be customized to patient-specific anatomy. These innovations enhance bone integration and clinical outcomes. The U.S. FDA approval of Desktop Metal's CMFlex 3D-printed graft in December 2022 demonstrates the growing acceptance of advanced technologies in dentistry.
The market is strengthened by collaborations aimed at expanding biomaterial portfolios and improving access to regenerative products. The 2023 Biocomposites acquisition of Artoss, and partnerships between Zimmer Biomet and RTI Surgical to support U.S. veterans, underscore how industry alliances drive product availability and clinical adoption.
Market Challenges
Despite strong growth prospects, challenges persist. Limited reimbursement coverage for grafting procedures in several countries increases out-of-pocket costs for patients, affecting adoption rates. In addition, potential risks-such as immunogenic reactions, limited osteoinductive properties, or inadequate bone formation-may restrict clinical use in some regions. Strict regulatory guidelines further slow product approvals and market penetration.
By Product Type
In 2024, the demineralized bone matrix (DBM) segment held the largest share, driven by high demand for implant procedures requiring enhanced bone regeneration. Meanwhile, synthetic bone graft substitutes are expected to grow fastest due to their availability, cost-effectiveness, and high biocompatibility.
By Form
Granules dominated the market in 2024, favored for their surface texture that promotes osteoblast attachment and stimulates osteogenesis. Putty and block forms are expected to expand with ongoing product innovations.
By End-User
Solo practices led the market in 2024, supported by strong patient preference and the high number of independent dental clinics performing grafting procedures. DSO/group practices are anticipated to grow rapidly due to centralized procurement and expanding procedural volumes.
Conclusion
The dental bone graft substitutes market is on a strong upward trajectory-progressing from USD 307.8 million in 2024 to USD 328.1 million in 2025, and reaching USD 529.4 million by 2032. With rising dental implant adoption, increased availability of advanced materials, and accelerating technological innovation, the market will continue to advance global regenerative dentistry and improve clinical outcomes for millions of patients.
Segmentation By Product Type
By Form
By End-user
By Regin